Veracyte, Inc. SEC filings VCYT
Veracyte, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Jul 2, 2015. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Jun 10, 2026 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 17, 2025 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 12, 2024 |
| DEFA14A | Additional proxy material | Jun 1, 2023 | — |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | — |
| PRE 14A | Preliminary proxy statement | Apr 17, 2023 | — |
| DEFA14A | Additional proxy material | Apr 26, 2022 | — |
| DEF 14A | Proxy statement | Apr 26, 2022 | Jun 15, 2022 |
| DEFA14A | Additional proxy material | Apr 23, 2021 | — |
| DEF 14A | Proxy statement | Apr 23, 2021 | Jun 7, 2021 |
| DEFA14A | Additional proxy material | Apr 24, 2020 | — |
| DEF 14A | Proxy statement | Apr 24, 2020 | Apr 24, 2020 |
| DEFA14A | Additional proxy material | Apr 24, 2019 | — |
| DEF 14A | Proxy statement | Apr 24, 2019 | Apr 24, 2019 |
| DEFA14A | Additional proxy material | Apr 19, 2018 | — |
| DEF 14A | Proxy statement | Apr 19, 2018 | Jun 6, 2018 |
| DEFA14A | Additional proxy material | Apr 21, 2017 | — |
| DEF 14A | Proxy statement | Apr 21, 2017 | Jun 6, 2017 |
| DEFA14A | Additional proxy material | May 6, 2016 | — |
| DEF 14A | Proxy statement | May 6, 2016 | Jun 17, 2016 |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- VCYT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1384101
- Former names
- CALDEROME INC (until Feb 27, 2008)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.